x
Filter:
Filters applied
- JLR Patient-Oriented and Epidemiological Research
- Dennis, Edward ARemove Dennis, Edward A filter
- diagnostic toolsRemove diagnostic tools filter
Publication Date
Please choose a date range between 2015 and 2018.
Author
- Quehenberger, Oswald2
- Arita, Makoto1
- Arita, Masanori1
- Armando, Aaron M1
- Armstrong, Michelle D1
- Barkley, Robert M1
- Bendt, Anne K1
- Brown, HAlex1
- Burla, Bo1
- Cazenave-Gassiot, Amaury1
- Clements, Ronald H1
- Duan, Jingjing1
- Ekroos, Kim1
- Fahy, Eoin1
- Glass, Christopher K1
- Gorden, DLee1
- Guan, Ziqiang1
- Gupta, Shakti1
- Han, Xianlin1
- Ikeda, Kazutaka1
- Ivanova, Pavlina T1
- Kelly, Samuel L1
- Leiker, Thomas J1
- Li, Chijun1
JLR Patient-Oriented and Epidemiological Research
2 Results
- Patient-Oriented and Epidemiological ResearchOpen Access
MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines
Journal of Lipid ResearchVol. 59Issue 10p2001–2017Published online: August 16, 2018- Bo Burla
- Makoto Arita
- Masanori Arita
- Anne K. Bendt
- Amaury Cazenave-Gassiot
- Edward A. Dennis
- and others
Cited in Scopus: 165Human blood is a self-regenerating lipid-rich biological fluid that is routinely collected in hospital settings. The inventory of lipid molecules found in blood plasma (plasma lipidome) offers insights into individual metabolism and physiology in health and disease. Disturbances in the plasma lipidome also occur in conditions that are not directly linked to lipid metabolism; therefore, plasma lipidomics based on MS is an emerging tool in an array of clinical diagnostics and disease management. However, challenges exist in the translation of such lipidomic data to clinical applications. - Patient-Oriented and Epidemiological ResearchOpen Access
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
Journal of Lipid ResearchVol. 56Issue 3p722–736Published online: January 17, 2015- D.Lee Gorden
- David S. Myers
- Pavlina T. Ivanova
- Eoin Fahy
- Mano R. Maurya
- Shakti Gupta
- and others
Cited in Scopus: 211The spectrum of nonalcoholic fatty liver disease (NAFLD) includes steatosis, nonalcoholic steatohepatitis (NASH), and cirrhosis. Recognition and timely diagnosis of these different stages, particularly NASH, is important for both potential reversibility and limitation of complications. Liver biopsy remains the clinical standard for definitive diagnosis. Diagnostic tools minimizing the need for invasive procedures or that add information to histologic data are important in novel management strategies for the growing epidemic of NAFLD.